59O

methyl 2-O-(4-chloro-2-nitrobenzoyl)-3-O-(4-methylbenzoyl)-beta-D-talopyranoside

Created:	2021-07-16
Last modified:	2022-07-13

Find Related PDB Entry
2 entries where 59O is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	56
Chiral Atom Count	5
Bond Count	58
Aromatic Bond Count	12

2D diagram of 59O

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	methyl 2-O-(4-chloro-2-nitrobenzoyl)-3-O-(4-methylbenzoyl)-beta-D-talopyranoside
Systematic Name (OpenEye OEToolkits)	[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-2-methoxy-4-(4-methylphenyl)carbonyloxy-5-oxidanyl-oxan-3-yl] 4-chloranyl-2-nitro-benzoate
Formula	C₂₂ H₂₂ Cl N O₁₀
Molecular Weight	495.864
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	COC1OC(CO)C(O)C(OC(=O)c2ccc(C)cc2)C1OC(=O)c1ccc(Cl)cc1[N+]([O-])=O
SMILES	CACTVS	3.385	CO[CH]1O[CH](CO)[CH](O)[CH](OC(=O)c2ccc(C)cc2)[CH]1OC(=O)c3ccc(Cl)cc3[N+]([O-])=O
SMILES	OpenEye OEToolkits	2.0.7	Cc1ccc(cc1)C(=O)OC2C(C(OC(C2OC(=O)c3ccc(cc3[N+](=O)[O-])Cl)OC)CO)O
Canonical SMILES	CACTVS	3.385	CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OC(=O)c3ccc(Cl)cc3[N+]([O-])=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1ccc(cc1)C(=O)O[C@H]2[C@H]([C@H](O[C@H]([C@H]2OC(=O)c3ccc(cc3[N+](=O)[O-])Cl)OC)CO)O
InChI	InChI	1.03	InChI=1S/C22H22ClNO10/c1-11-3-5-12(6-4-11)20(27)33-18-17(26)16(10-25)32-22(31-2)19(18)34-21(28)14-8-7-13(23)9-15(14)24(29)30/h3-9,16-19,22,25-26H,10H2,1-2H3/t16-,17+,18+,19+,22-/m1/s1
InChIKey	InChI	1.03	FSBFERQGFVBNEJ-NOYKIMNZSA-N

Related Resource References

Resource Name	Reference
PubChem	164513432

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.